NCT02899715: Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma |
|
|
| Recruiting | 1 | 30 | US | Laboratory Biomarker Analysis, Panobinostat, Faridak, Farydak, LBH589, Pharmacological Study | National Cancer Institute (NCI) | Diffuse Intrinsic Pontine Glioma | 10/19 | | | |
